DR. TODD JEFFREY BRINTON, M.D.
Osteopathic Medicine at Miranda Ave, Palo Alto, CA
License number
California A75795
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
3801 Miranda Ave, Palo Alto, CA 94304
1067 Marcussen Dr, Menlo Park, CA 94025
1067 Marcussen Dr, Menlo Park, CA 94025
Phone
(650) 493-5000
Professional information
Todd Jeffrey Brinton, Palo Alto CA
Specialties:
Cardiologist
Address:
3801 Miranda Ave, Palo Alto, CA 94304
Education:
Doctor of Medicine
Stanford Hospital & Clinics - Fellowship - Cardiovascular Medicine
Stanford Hospital & Clinics - Fellowship - Cardiovascular Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine), American Board of Internal Medicine Sub-certificate in Interventional Cardiology (Internal Medicine)
Dr. Todd J Brinton - MD (Doctor of Medicine)
Hospitals:
Stanford Office
300 Pasteur Dr STE A260, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Stanford Office
300 Pasteur Dr STE A260, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
300 Pasteur Dr STE A260, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Stanford Office
300 Pasteur Dr STE A260, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical Schools
Rosalind Franklin University Of Medicine Science/The Chicago Medical School
Graduated: 2000
Rosalind Franklin University Of Medicine Science/The Chicago Medical School
Graduated: 2000
Use Of Platelet Rich Plasma Composition In The Treatment Of Cardiac Conduction Abnormalities
US Patent:
2010011, May 6, 2010
Filed:
Oct 7, 2009
Appl. No.:
12/575314
Inventors:
Allan Kumar Mishra - Menlo Park CA, US
Todd Jeffrey Brinton - Menlo Park CA, US
Todd Jeffrey Brinton - Menlo Park CA, US
Assignee:
BioParadox, LLC - Menlo Park CA
International Classification:
A61K 35/16, A61M 25/00, A61N 1/362, A61P 9/00
US Classification:
424530, 604506, 607 3
Abstract:
Methods and kits for treating a cardiac arrhythmia using a platelet rich plasma (PRP) composition are provided. Any type of arrhythmia may be treated using the PRP composition. The PRP composition may comprise PRP developed using blood collected from a patient suffering the cardiac arrhythmia. The PRP composition may be buffered to a physiological pH and may include one or more anti-arrhythmic agents, anti-coagulants, or other drugs. The PRP composition may be delivered using a nebulizer, minimally invasively, or surgically. In some embodiments, the PRP composition may be coated on one or more medical devices. The PRP composition may be delivered to an identified portion of the electrical conduction system of the heart affected and/or causing the arrhythmia to occur.
Methods And Apparatus For Localized And Semi-Localized Drug Delivery
US Patent:
2005005, Mar 17, 2005
Filed:
Feb 20, 2004
Appl. No.:
10/783217
Inventors:
Michi Garrison - Half Moon Bay CA, US
Todd Brinton - Menlo Park CA, US
Peter Campbell - Santa Clara CA, US
Steve Roe - San Mateo CA, US
Stephen Salmon - Napa CA, US
Paul Yock - Atherton CA, US
Todd Brinton - Menlo Park CA, US
Peter Campbell - Santa Clara CA, US
Steve Roe - San Mateo CA, US
Stephen Salmon - Napa CA, US
Paul Yock - Atherton CA, US
International Classification:
A61M029/00
US Classification:
604101040
Abstract:
A catheter system for localized or semi-localized administration of agents through the wall of a blood vessel is provided. Various catheter system constructions which use at least one expandable occluding device to create an isolated region are provided. Constructions using one catheter and one occlusion device are provided, along with constructions using two catheters and multiple occlusion devices. The catheter system may include a catheter with a variable stiffness along its length. The catheter system may also include a guide wire integrated with an inner catheter. The catheter can infuse the agent into the blood vessel in a pressure regulated manner. Methods for delivery and infusion of the agent within a blood vessel are also provided.